Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development
about
Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiencyAcromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis.Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Management of acromegaly in Latin America: expert panel recommendationsUse of Pegvisomant in acromegaly. An Italian Society of Endocrinology guidelineGH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90Medical therapy of acromegalyChronic activity-based therapy does not improve body composition, insulin-like growth factor-I, adiponectin, or myostatin in persons with spinal cord injuryAAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects.Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease.Insulin-like growth factor-I (rhIGF-I) therapy of short stature.Reference Values for IGF-I Serum Concentrations: Comparison of Six ImmunoassaysIdiopathic short stature: conundrums of definition and treatment.How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management.Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?Monomorphous Plurihormonal Pituitary Adenoma of Pit-1 Lineage in a Giant Adolescent with Central Hyperthyroidism.
P2860
Q24654465-09272A95-CC75-4234-BC58-347F47EDE135Q33569037-FD954EBD-1422-47DF-812B-CA85F9CF9CC5Q33569159-91FF5294-F56F-4542-BCD1-D1244E67ACEEQ33794388-57423E21-664D-422E-A3FD-F82751BBF9D1Q34277844-D22E46B9-3BCD-4DB0-A086-C6178C3C237FQ35103887-688E5FEA-4D0B-40E4-93FA-810DD5095907Q35895856-969D2711-00C4-4895-8B67-D069EA745664Q35951326-B5F4E641-B77F-4EBB-88BA-3F4474C74FA7Q36818188-FA2A3ED6-8BD6-4DC1-ACCB-E48A467EEE08Q37145687-9E71648F-801E-4F8A-982A-3B19C31CFFB0Q37192175-344D140C-24EC-45DC-B08C-0A786F37C4ABQ37318566-9C01AE5F-FF30-403E-853B-2AC204BAB16DQ37420800-6FCB04AA-B3A5-415E-8D08-A65F5E4AB697Q37930510-607B2ABF-BE8A-4079-B3C3-D8A7E3B63CFFQ38185306-7675338F-2387-4318-B159-D38FF1EC7191Q48766407-395F9183-EBFD-43CC-9600-C00B1D68031EQ53359981-D353BFE0-79CB-40A1-8040-059D8AF306C7
P2860
Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Variability and reliability of ...... ratios in disease development
@ast
Variability and reliability of ...... ratios in disease development
@en
type
label
Variability and reliability of ...... ratios in disease development
@ast
Variability and reliability of ...... ratios in disease development
@en
prefLabel
Variability and reliability of ...... ratios in disease development
@ast
Variability and reliability of ...... ratios in disease development
@en
P2093
P2860
P356
P1476
Variability and reliability of ...... ratios in disease development
@en
P2093
Ann Danoff
Daniela Milani
David L Kleinberg
Joan Welkowitz
John D Carmichael
Richard E Reitz
P2860
P304
P356
10.1210/JC.2003-032150
P407
P577
2004-05-01T00:00:00Z